Immunoassay Reagent Alinity i Hepatitis A Virus IgG II CLIA Non-Waived For Alinity i System 2 X 200 Test

Features

• The HAVAb IgG II assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibody to hepatitis A virus (IgG anti-HAV) in human adult and pediatric (4 through 21 years) serum (collected in serum and serum separator tubes) and plasma (collected in sodium heparin, lithium heparin, lithium heparin separator, dipotassium EDTA, and tripotassium EDTA tubes) from patients with signs and symptoms or at risk for hepatitis A on the Alinity i system
• The HAVAb IgG II assay is used to determine the immune status of individuals to hepatitis A virus (HAV) infection
• This assay is an automated, two-step immunoassay for the qualitative detection of IgG anti-HAV in human adult and pediatric serum and plasma from patients with signs and symptoms or at risk for hepatitis using chemiluminescent microparticle immunoassay (CMIA) technology
• WARNING: This product can expose you to chemicals which are known to the State of California to cause cancer, birth defects or other reproductive harm. For more information, go to www.p65Warnings.ca.gov.

More Information

• SDS